skip to Main Content

A Phase 3 Randomized, Double-Blind Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Remdesivir (GS-5734) Treatment of COVID-19 in an Outpatient Setting

This clinical trial will evaluate treatment with IV administered remdesivir in an outpatient setting in patients with COVID-19 who are at risk for disease progression.

Investigator: Skarbinski, Jacek

Funder: Gilead Sciences, Inc.

Explore all studies and publications

Back To Top